AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports
AstraZeneca, a prominent player in the race to develop a COVID-19 vaccine, has made a significant announcement to withdraw its vaccine globally, according to reports from The Telegraph. This decision comes amidst a backdrop of shifting preferences where vaccines from Pfizer and Moderna have become more accessible and favored by the public. While AstraZeneca initially had the advantage of easier storage requirements compared to its counterparts, recent developments have led to its diminishing popularity.
Research indicates that the AstraZeneca vaccine has been associated with a higher risk of blood clots, prompting concerns among the public. The British Heart Foundation highlights that for every 10 million individuals vaccinated with AstraZeneca, there are additional cases of blood clots compared to the occurrence of similar conditions with a COVID-19 infection.… Continue reading
John Q. Hosedrinker